GlassScriptPhysician profile
Christopher M Herndon
NPI 1578563672
$432.84
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $15.25 · 2021: $35.79 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3b Medical, INC. | $165.63 | 2024 | Luna |
| Abbvie INC. | $35.79 | 2021 | |
| Glaxosmithkline, LLC. | $32.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.15 | 2019 | |
| Lilly USA, LLC | $28.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.38 | 2019 | |
| Nevro Corp. | $20.89 | 2024 | Senza |
| Novo Nordisk INC | $19.77 | 2019 | |
| Boston Scientific Corporation | $16.73 | 2019 | |
| Pfizer INC. | $15.25 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.27 | 2019 | |
| Astellas Pharma US INC | $13.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Herndon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.